EVOX THERAPEUTICS

Serial Number 79209128
603

Registration Progress

Application Filed
Dec 15, 2016
Under Examination
Approved for Publication
Published for Opposition
Registered

Trademark Image

EVOX THERAPEUTICS

Basic Information

Serial Number
79209128
Filing Date
December 15, 2016
Abandonment Date
April 5, 2022
Drawing Code
4

Status Summary

Current Status
Inactive
Status Code
603
Status Date
Apr 5, 2022
Classes
005 042

Rights Holder

Evox Therapeutics Limited

98
Address
Oxford Science Park,
Medawar Centre, 2nd Floor East Building, Robert Robinson Avenue Oxford, Oxfordshire OX4 4HG
GB

Ownership History

Evox Therapeutics Limited

Original Applicant
99
GB

Evox Therapeutics Limited

New Owner Before Publication #1
98
GB

Legal Representation

Attorney
BRYCE J MAYNARD

USPTO Deadlines

All Deadlines Cleared

All 4 deadline(s) have been cleared by subsequent events. No active deadlines at this time.

Application History

50 events
Date Code Type Description Documents
Nov 25, 2024 ADCH M CHANGE OF NAME/ADDRESS REC'D FROM IB Loading...
Apr 24, 2023 FINT P FINAL DECISION TRANSACTION PROCESSED BY IB Loading...
Apr 5, 2023 FICS P FINAL DISPOSITION NOTICE SENT TO IB Loading...
Apr 5, 2023 FICR P FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB Loading...
Apr 5, 2022 MAB3 E ABANDONMENT NOTICE MAILED - AFTER EX PARTE APPEAL Loading...
Apr 5, 2022 MAB3 O ABANDONMENT NOTICE MAILED - AFTER EX PARTE APPEAL Loading...
Apr 5, 2022 ABN3 O ABANDONMENT - AFTER EX PARTE APPEAL Loading...
Apr 5, 2022 EXPT T EXPARTE APPEAL TERMINATED Loading...
Feb 22, 2022 EXFB T EXPARTE APPEAL DISMISSED - FAILURE TO FILE BRIEF Loading...
Dec 8, 2021 GEA1 O NOTIFICATION OF ACTION DENYING REQ FOR RECON E-MAILED Loading...
Dec 8, 2021 CNCF S ACTION CONTINUING FINAL - COMPLETED Loading...
Dec 8, 2021 GECD O ACTION DENYING REQ FOR RECON E-MAILED Loading...
Dec 4, 2021 NREP P NEW REPRESENTATIVE AT IB RECEIVED Loading...
Oct 25, 2021 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED Loading...
Oct 25, 2021 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
Oct 20, 2021 EXPI T EX PARTE APPEAL-INSTITUTED Loading...
Oct 20, 2021 JURT T JURISDICTION RESTORED TO EXAMINING ATTORNEY Loading...
Oct 20, 2021 EXAF T EXPARTE APPEAL RECEIVED AT TTAB Loading...
Oct 19, 2021 ERFR I TEAS REQUEST FOR RECONSIDERATION RECEIVED Loading...
Apr 19, 2021 GNS1 O NOTIFICATION OF SUBSEQUENT FINAL EMAILED Loading...
Apr 19, 2021 CFRC R SUBSEQUENT FINAL REFUSAL WRITTEN Loading...
Apr 19, 2021 GNSF O SUBSEQUENT FINAL EMAILED Loading...
Mar 9, 2021 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED Loading...
Mar 9, 2021 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
Mar 9, 2021 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED Loading...
Mar 9, 2021 CHAN I APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED Loading...
Mar 9, 2021 TCCA I TEAS CHANGE OF CORRESPONDENCE RECEIVED Loading...
Mar 9, 2021 ECDR I TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS Loading...
Mar 9, 2021 EWAF I TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS Loading...
Mar 9, 2021 ARAA I ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED Loading...
Mar 9, 2021 REAP I TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED Loading...
Mar 9, 2021 COAR I TEAS CHANGE OF OWNER ADDRESS RECEIVED Loading...
Sep 10, 2020 GNRN O NOTIFICATION OF NON-FINAL ACTION E-MAILED Loading...
Sep 10, 2020 GNRT O NON-FINAL ACTION E-MAILED Loading...
Sep 10, 2020 CNRT R NON-FINAL ACTION WRITTEN Loading...
Aug 19, 2020 RCCK S SUSPENSION CHECKED - TO ATTORNEY FOR ACTION Loading...
Jul 30, 2020 NREP P NEW REPRESENTATIVE AT IB RECEIVED Loading...
Feb 10, 2020 RCSC S REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED Loading...
Aug 6, 2019 RCSC S REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED Loading...
Feb 6, 2019 RCSC S REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED Loading...
Feb 6, 2019 ALIE A ASSIGNED TO LIE Loading...
Nov 23, 2018 OPNX P NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB Loading...
Nov 7, 2018 OPNS P NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB Loading...
Nov 7, 2018 OPNR P NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB Loading...
Jul 20, 2018 GNS3 O NOTIFICATION OF LETTER OF SUSPENSION E-MAILED Loading...
Jul 20, 2018 GNSL S LETTER OF SUSPENSION E-MAILED Loading...
Jul 20, 2018 CNSL R SUSPENSION LETTER WRITTEN Loading...
Jun 27, 2018 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED Loading...
Jun 27, 2018 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
Jun 27, 2018 ERFR I TEAS REQUEST FOR RECONSIDERATION RECEIVED Loading...

Detailed Classifications

Class 005
Drug delivery agents in the form of exosomes that facilitate the delivery of pharmaceutical preparations; biological preparations comprising exosome for medical use; biological reagents comprising exosome for medical use; mixed biological preparations comprising exosome for pharmaceutical and medical use; diagnostic reagents comprising exosome for medicinal use in the fields of biology, genetic engineering and pharmaceuticals; diagnostic kits comprised of medical diagnostic reagents and assays for testing of exosomes for use in the detection of infectious diseases, cancer, diabetes, obesity, metabolic syndrome, dementia, mitochondrial disease, neuromuscular disease, inflammatory diseases and autoimmune disorders
Class 042
Scientific, medical and pharmaceutical research and development services; pharmaceutical drug development services; research and development of pharmaceutical preparations; biological research; clinical research in the field of transformational therapeutics; providing medical and scientific research information in the field of filtration of exosomes from blood; scientific investigations for medical purposes; scientific laboratory services; medical research laboratory services; laboratory research services relating to pharmaceuticals; research and development in the field of biotherapeutics for the treatment of infectious diseases and metabolic disorders; consulting services in the fields of biotechnology, pharmaceutical research and development and genetic science

Classification

International Classes
005 042

Disclaimers

The following terms have been disclaimed and are not claimed as part of the trademark:
Specific Disclaimer
"THERAPEUTICS"